Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Medication non-adherence has an important impact on treatment efficacy and healthcare burden across a range of conditions and therapeutic areas. The aim of this analysis was to determine predictors of non-adherence and impact of non-...

Full description

Bibliographic Details
Main Authors: Kooij J J Sandra, Rösler Michael, Philipsen Alexandra, Wächter Sandra, Dejonckheere Joachim, van der Kolk Annemarie, van Agthoven Michel, Schäuble Barbara
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Psychiatry
Subjects:
Adherence
Adults
ADHD
CAARS:O-SV
Efficacy
Compliance
Non-adherence
OROS methylphenidate
Online Access:http://www.biomedcentral.com/1471-244X/13/36

Internet

http://www.biomedcentral.com/1471-244X/13/36

Similar Items